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The biology of foamy viruses, their mode of transmission and disease potential in their natural host and after interspecies transmission are
largely unknown. To gain insights into the prevalence of bovine foamy virus (BFV) and its zoonotic potential, enzyme-linked immunosorbent
assays (ELISAs) were established to determine antibody responses against Gag, Env, and the non-structural protein Bet in bovine serum and milk.
In Polish cattle, strong Gag reactivity was most frequent (41.5%) and strongly associated with Bet antibodies, Env antibodies were less frequent.
German cattle showed a low overall BFV antibody prevalence of 6.8%. Besides clearly BFV-positive animals, a substantial number of weakly
reacting cattle were identified. BFV-specific antibodies were also detectable in milk.
BFV was isolated from PBLs and milk cells of BFV-positive cattle but not from antibody-negative or weakly reacting animals. The
implications of these findings for the potential interspecies transmission of BFV to humans will be discussed.
© 2007 Elsevier Inc. All rights reserved.Keywords: Foamy virus; ELISA; Humoral immunity; Milk-borne infection; Diagnostic marker; ZoonosisIntroduction
Spumaretroviruses or foamy viruses (FVs) are a distinct
subfamily of retroviruses that are under development as novel
viral vectors for gene delivery and vaccination (Josephson et al.,
2002; Linial, 1999; Rethwilm, 2003; Schwantes et al., 2003).
Similar to the more intensely studied lentiviruses, FVs have a
complex genetic makeup (Rethwilm, 2003) encoding the
canonical retroviral Gag, Pol, and Env proteins and the
regulatory Bel1/Tas transactivator. In addition, the accessory⁎ Corresponding author. Dept. Genome Modifications and Carcinogenesis,
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doi:10.1016/j.virol.2007.03.009Bet protein counteracts cellular APOBEC3-mediated restriction
and may have a role in particle release and in establishing viral
persistence (Alke et al., 2001; Löchelt et al., 2005; Meiering and
Linial, 2002; Russell et al., 2005; Saib et al., 1995). In contrast
to the well-established molecular biology of FVs, insights into
FV replication in the infected individual, the sites of FV
replication, the authentic target cell(s), the potential disease
association, and the extent of virus replication during life-long
persistence are limited at present.
Interspecies transmission of simian FVs (SFV) from
chimpanzee, African green monkeys, and baboons into humans
has been repeatedly detected (Heneine et al., 2003). Human
populations with an endemic FV are not known at present, and
thus the prototypic human FV isolate HFV is considered to be a
primate FV (PFV). Interspecies infections occur either in simian
caretakers who had been bitten by these primates (Heneine et
al., 1998), in Africans exposed to simian organs and body fluids
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and in humans with close contact to pet simians or temple
monkeys (Jones-Engel et al., 2006; Schillaci et al., 2005). In the
few human cases of interspecies FV infections, no disease has
been associated with these events and no further transmission to
other humans has occurred (Heneine et al., 2003). The
containment of FV interspecies transmissions may be in part
due to the species-specific protective function of Bet that
efficiently inactivates APOBEC3 proteins of the cognate host
but not of distantly related animals including humans (Löchelt
et al., 2005; Russell et al., 2005). However, any interspecies
transmission independent of whether it results in a productive or
only a restricted replication may bear a disease potential since
severe neurological disease consistently occurs in HFV-
transgenic mice (Aguzzi et al., 1996).
The first isolation of a FV from cattle was reported in 1969
(Malmquist et al., 1969). Since then, several studies have shown
that BFV, also designated bovine spumaretrovirus or syncytial
virus, is prevalent in a relatively high percentage of cattle
(Appleby, 1979; Greig, 1979; Jacobs et al., 1995; Malmquist et
al., 1969). BFV-specific antibodies were detected by immuno-
diffusion and immunofluorescence (IF) and proviral BFV DNA
was identified by different PCR techniques (Granzow, 1983;
Johnson et al., 1983; Malmquist et al., 1969; Materniak et al.,
2006; Pamba et al., 1999). The reported prevalence values vary
considerably which may be either due to geographic differences
or different detection methods that do not allow direct
comparison of the data. For other FVs, PCR-mediated genome
identification, sero-reactivity against Gag and Bet proteins in
blotting or ELISA, and IF techniques are considered to be the
most reliable detectionmethods (Alke et al., 2000; Hussain et al.,
2003; Khan et al., 1999; Romen et al., 2006; Winkler et al.,
1998). Finally, virus isolation is the gold standard to diagnose
infections.
Here we present a fast and reliable antibody screening
platform suited for bovine milk and serum allowing broad
screening for BFV prevalence. Surveillance of cattle appearsFig. 1. Validation of BFV Gag, Bet, and Env ELISAs using Polish cattle sera. Ten BFV
negative sera were clearly distinguishable regarding sero-reactivity against Gag and B
general lower titers.mandatory since infectious BFV can be isolated from raw milk
pointing to the risk of BFV transmission to men.
Results
Expression of recombinant BFV Gag, Env, and Bet fusion
proteins and set-up of ELISAs
ELISAs were based on previously established generic assays
for feline FV (FFV) antibodies (for technical detail, see Romen
et al., 2006). The BFV structural protein Gag, the envelope-
leader protein and SU ecto-domains (Env), and the accessory Bet
protein (Holzschu et al., 1998; Renshaw et al., 1991; Renshaw
and Casey, 1994) were expressed as fusion proteins flanked by a
N-terminal glutathione-S-transferase (GST) domain and a C-
terminal SV40-derived tag (Sehr et al., 2001, 2002). The three
BFV fusion proteins were soluble and predominantly full-length
(data not shown). Recombinant BFV fusion proteins were
adsorbed from cleared bacterial lysates to the ELISA plates as
described (Sehr et al., 2001).
Validation of the BFV Gag, Env, and Bet ELISAs using bovine
reference sera
To validate sero-reactivity against the three BFV proteins, we
used reference sera from 12 naturally BFV-infected and 10
uninfected Polish cattle. Their BFV-infection status had been
before unequivocally established by four independent assays:
two BFV DNA PCRs (Pamba et al., 1999), an antibody ELISA
based on BFV-infected cells (Materniak, manuscript in prepara-
tion), and a BFV-specific agar gel immuno-diffusion (AGID)
assay (Johnson et al., 1983) also detecting BFV-specific
antibodies (data not shown).
In the novel ELISAs, sera were used at 1:50 dilutions. Sera
from BFV-negative cattle exhibited some baseline reactivity
(expressed as optical density units or milli-optical density units
at wave length 450 nm, OD450 and mOD450, respectively)-negative and 12 BFV-positive cattle reference sera were analyzed. Positive and
et. Env antibodies were not consistently present in BFV-infected cattle and had in
Fig. 2. Histogram plot of Gag antibody reactivity in serum samples of cattle from
Poland (A; n=89) and Germany (B; n=190). Whereas Gag reactivity in Polish
cattle showed a bimodal distribution with most sera having either very low or
strong reactivity, there was a substantial number of weak reactors (between
standard and stringent cut-off) detectable in German cattle. Standard and
stringent cut-offs are indicated as dashed and full lines.
125F. Romen et al. / Virology 364 (2007) 123–131towards all three BFV antigens, reaching up to 198 mOD450
against Gag in one serum (Fig. 1). However, all sera from BFV-
positive animals showed much higher reactivity against Gag
(>750 mOD450), followed by Bet (>350 mOD450), and 9/12
animals showed reactivity against Env above 150 mOD450 (Fig.
1). Standard cut-off values were calculated from the negative
reference sera as the mean value plus three standard deviations
(M+3 SD, see Materials and methods) and were 218 mOD450
for Gag, 217 mOD450 for Bet and 124 mOD450 for Env with no
outliers. The comparably high background values in the BFV
ELISAs might be related to the fact that a Protein-G conjugate
had to be used for the specific detection of bovine IgG instead of
Protein-A which does not allow detection of all bovine IgG
subclasses.
None of the reference sera showed elevated Bet or Env
reactivity in the absence of Gag reactivity (Fig. 1). In summary,
the ELISA reactivity of the reference animals for Gag and Bet
closely correlated with their BFV-infection status as determined
by the other detection methods (PCRs, cell-based ELISA,
AGID) while Env-specific antibodies were only found in 9/12
BFV-positive animals. The number of multiple reactivity of the
BFV reference sera is slightly higher than in FFV-infected cats
(Romen et al., 2006). The reproducibility of independently
performed ELISAs with two different Gag antigen batches was
high (R2 =0.97).
BFV-specific antibodies in field sera of 89 Polish cattle
Using the newly developed ELISA, we analyzed field sera
from 89 randomly selected Polish dairy cows that had been
tested before by nested BFV-PCR. BFV Gag reactivity was
bimodal with peaks at about 100 mOD450 and greater than
600 mOD450 (Fig. 2A). Using the standard cut-off value of
218 mOD450 for Gag, 38 sera (42.7%) scored positive. One
serum from each the BFV-negative reference animals (198
mOD450) and the Polish field study (308 mOD450) displayed
reactivity close to the standard cut-off. When applying a more
stringent, doubled cut-off of 2×(M+3 SD) of 436 mOD450
(see Materials and methods), all BFV-positive reference cattle
still scored positive while the single weakly reacting field
serum now scored negative. This particular animal was
negative in (i) BFV-PCR, (ii) Bet and Env serum antibody
ELISAs, and (iii) milk antibody ELISAs for any BFV antigen
(data not shown and see below). Thus, Gag sero-reactivity
above the stringent cut-off is referred as strong-positive
indicative for BFV infection while animals with reactivity
between standard and stringent cut-off are designated weak-
positive with an unclear BFV infection status. Based on these
values, 41.5% of the tested Polish cattle were considered
BFV-infected.
Bet and Env reactivity did not exhibit a bimodal dis-
tribution. Reactivity against these antigens may have limited
diagnostic value as previously seen for FFV-infected cats
(Romen et al., 2006). Using the standard and the deduced
stringent cut-off values for Bet and Env (Figs. 3A and B), a
clear correlation of strong Bet and strong Gag reactivity was
detectable (25/37) while 10 strongly Gag-positive animals hadweak Bet reactivity. The stability index (R2 value) for Gag and
Bet reactivity was 0.77. In contrast, only 9 strongly Gag-
positive animals were strongly Env-positive while 16 showed
weak Env antibody titres. No Env reactivity was detected in
Gag-negative animals whereas two Gag-negative animals
scored weakly positive for Bet. Six animals were strongly
positive for all three antigens, 22 were strongly double-positive
(19 Gag plus Bet and 3 Gag plus Env), while 9 sera showed only
strong Gag reactivity.
All strongly Gag-positive sera (n=37) were PCR-positive
while the single weakly reacting animal was PCR-negative.
Reproducibly, five animals negative in ELISA and AGID
assays were positive in a pol/env double PCR. These animals
were unfortunately not available for confirmatory testing but
none of them exhibited threshold reactivity to any of the BFV
antigens in serum or milk indicating that these animals are either
at a very early stage of infection or that the pol/env double PCR
results might be inaccurate. In summary, the data confirm that
Fig. 3. Association of Gag plus Bet and Gag plus Env sero-reactivities of 89
Polish (white diamonds) and 190 German (black diamonds) cattle depicted in
two-dimensional scatter plots. Each diamond represents a data pair of an
individual serum. Dashed and full lines indicate standard and stringent cut-off
values, respectively.
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reactivity has only supportive value.
Detection of BFV antibodies in milk and comparison to blood
serology
We then tested whether the matched milk samples of these 89
Polish cows contain BFV-specific antibodies as had been shown
for other cattle infections, for instance with bovine leukaemia
and bovine viral diarrhoea virus and for Neospora caninum
(Carli et al., 1993; Hall et al., 2006; Niskanen et al., 1989). Milk
was used at a dilution of 1:5. A comparison of 15 representative
serum and milk pairs is shown in Fig. 4. A clear but non-linear
correlation was in general obvious for Gag (see below) while
Bet and Env reactivity showed a higher degree of variation
between serum and milk. Cut-off levels for all three antigens
were calculated from the 52 BFV sero-negative Polish cows
(see Materials and methods). For milk antibodies, standard cut-
off values were 186 for Gag 192 for Bet, and 107 mOD450 for
Env; stringent cut-off values were 372, 384, and 214 mOD450,respectively. Of the 37 strongly Gag sero-positive animals, 34
showed strong and 1 weak Gag reactivity in the milk. The
correlation of serum versus milk data for Bet and Env was less
stringent (Table 1). None of the sero-negative cows scored
positive for BFV antibodies in milk.
BFV-specific antibodies in sera and milk of 190 German cattle
Using the cut-off values as defined by the Polish reference
animals, we analyzed sera and milk samples of 144 German
dairy cows (aged between 2.5 and 6 years) from 11 farms in
South Germany taken during general examination by veterinar-
ian disease surveillance and 46 calves (ages between 5 and
7 months) from three farms in the northeast of Germany. The
overall pattern of reactivity of the sera was similar in both
groups. Among the calves, 4 out of 46 (8.7%) were strongly
Gag-positive while the dairy cows showed a BFV-prevalence of
9 out of 144 (6.3%). However, the median Gag reactivity of
positive adult cows was slightly higher than that of calves (944
versus 818 mOD450). Due to the similar overall reactivity, the
data from the German cattle were combined. The histogram for
all German animals indicates significant differences in the
distribution of Gag reactivity compared to Polish cattle (Fig. 2).
The overall prevalence of strong BFV Gag reactivity in
Germany (13 out of 190 animals; 6.8%) is much lower than
in Poland. Out of the 13 strongly Gag-positive German sera,
eight had also strong Bet, seven strong Env, and one displayed
weak Env reactivity. In addition, nine German animals were
weakly Gag-reactive, one had weak Gag plus weak Bet
reactivity, and another displayed weak reactivity against all
three BFV antigens.
In total, 18 selected cows from South Germany were studied
for BFV isolation (for details, see below): BFV was only
recovered from animals with strong Gag reactivity (3/3). In
contrast, Gag-negative animals or those with weak Gag
antibodies (n=15) did not allow BFV isolation showing high
assay consistency for strongly BFV Gag-positive and Gag-
negative sera. A lower assay consistency was observed between
BFV IF and the novel ELISA: three out of four ELISA-positive
calf sera were also scored positive in IF whereas one ELISA-
positive serum was scored weakly positive in the IF test.
Virus isolation from blood, milk and saliva
Blood, milk and saliva samples from 18 dairy cows from
Germany were studied for BFV isolation: three were strongly
Gag-positive (900–1000 mOD450) and also contained Gag-
specific antibodies in the milk, three cows had no milk
reactivity but two displayed weak Gag reactivity and another
had weak Gag plus Bet reactivity, and 12 were clearly Gag-
negative. Saliva, enriched PBLs, and milk cells were co-
cultivated with permissive dog thymus cells (Cf2Th). These
cultures were examined for signs of BFV infection (induction of
multi-nucleated syncytia) for up to 4 weeks. The cultures with
PBLs from the three strongly positive cows developed syncytia
14 days p.i. and BFV infection was confirmed by direct IF (Fig.
5). Importantly, BFV was also isolated from two milk cell
Fig. 4. BFV-specific antibodies in paired serum and milk samples of 15 representative Polish cattle. Gag and Bet antibodies were consistently detected in both samples
whereas Env antibody pattern showed a less strong agreement.
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(syncytia formation and IF). The cultures with all other samples
remained virus free, indicating that these animals were not
producing infectious virus (no viremia) at the time of sampling
or the isolated virus amount did not exceed infection thresholds.
Under the conditions used, saliva samples were negative forTable 1
Comparison of serum- and milk-based BFV diagnosis
Sample and antigen Cut off PPV (%) NPV (%)
Milk Gag Standard 94.6 96.2
Stringent 100 94.5
Milk Bet Standard 96.6 85.0
Stringent 100 76.5
Milk Env Standard 93.3 68.9
Stringent 100 62.7
Positive and negative predictive values (PPV and NPV, respectively) of milk
ELISA results depending on the antigens and cut-off values used. As reference,
the diagnosis based on the stringent Gag serum cut-off was used.BFV contrary to previous reports (Johnson et al., 1988). This
result has to be viewed with caution since saliva co-cultivation
was in general difficult and only possible in the presence of high
amounts of antibiotics and repeated media changes.
Discussion
We have developed novel ELISAs for the sensitive and
specific detection of antibodies against three BFV proteins. The
ELISAs were validated using defined reference sera from
naturally infected cattle. The structural protein Gag was shown
to be the diagnostic antigen of choice. This clearly corresponds
to the general observation that reactivity towards Gag, either in
ELISA or immunoblots is diagnostic for FV infection in
primates (including zoonotically infected humans) and cats
(Alke et al., 2000; Hussain et al., 2003; Khan et al., 1999;
Romen et al., 2006; Winkler et al., 1998). According to our data,
the stringent Gag cut-off is a valuable parameter to positively
identify productively BFV-infected animals as shown by the
Fig. 5. Direct IF (left-hand panel) and phase contrast microscopic images (right-hand panel) of Cf2Th cells infected with BFV from cattle PBLs (top panel) and raw-
milk cells (middle panel). The lower panel represents uninfected controls. The IF staining of cells displaying BFV-induced cytopathic effects (syncytia, top and middle
panel) was done with a FITC-labelled BFV reference serum (Granzow et al., 1983).
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tests to identify BFV-infected cattle. Similarly, the standard
Gag cut-off appears well suited for the unambiguous negative
identification of non-infected, BFV-negative cattle. However,
one Polish and some German cattle have been identified with
weak Gag reactivity. These intermediate reactants show mainly
singular weak reactivity against Gag or, less frequently,
additional low-level reactivity against BFV Bet and/or Env.
Since weak reactivity was not overrepresented in calves, this
reactivity is not due to maternal antibodies. Although only few
weakly reacting dairy cows have been tested, BFV was not
isolated from their blood that is otherwise a reliable source of
virus to identify persistently FV-infected animals. Thus, it
might be that these animals are either at a very early stage of
infection or that these animals are not productively infected or
have cleared the virus as recently discussed for sheep
lentiviruses (Herrmann-Hoesing et al., 2007). We assume,
however, that the weak reactivity is because these animals
were solely exposed to BFV antigens but were not produc-
tively BFV-infected. German calves are frequently fed with dry
milk products and the weak sero-reactivity detected might have
resulted from exposition to such milk-derived BFV antigens inthe form of inactivated viruses or virus-producing cells. The
situation in Poland appears to be different in that calves are
generally fully nursed and a high percentage might have been
productively infected by BFV thus leading to strong and
frequent BFV-specific reactivity. It will be necessary to further
characterize and define the group of weakly reacting animals
with respect to BFV infection and serology. Bet and Env
reactivity may be for instance a suited additional marker to
characterize the group of weakly reacting animals. In addition,
the use of three diagnostic antigens may also allow defining
different stages of infection or viral load, issues that should be
analyzed in more detail.
In our small-scale study of German cattle, the frequency of
BFV antibodies appears to be similar in calves and dairy cows
indicating that virus transmission occurs early in live. This
would indicate intra-uterine or peri- or post-partum infection of
calves as discussed previously (Appleby, 1979; Lucas et al.,
1986; van der Maaten et al., 1973). The isolation of BFV from
milk cells described here and earlier (Malmquist et al., 1969)
even indicates milk-borne infections in the presence of maternal
antibodies in the whey. However, our findings and conclusions
are not supported by others (Johnson et al., 1988). We will
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studies using the novel BFV ELISAs described here.
The difference in BFV prevalence in German (about 7%) and
Polish (42%) cattle and published data (Granzow et al., 1983)
may be attributed to differences in livestock husbandry. Polish
cattle are often kept in herds of variable size but with close
contact to each other especially among calves and dams for
nursing. Mother–offspring transmission of BFV via milk may
be more common in Poland than in Germany in line with
previous reports that BFV transmission may be restricted to
young animals (Appleby, 1979; Lucas et al., 1986). In Germany,
cattle are often kept under semi-industrial conditions with less
contact between the animals reducing BFV transmission. In
support of this hypothesis, a re-examination of cattle from two
German farms after 1 year did not identify newly infected
animals and BFV prevalence in Germany appears to be age-
independent. In summary, our data indicate that (i) BFV
contagiosity is comparably low, (ii) the conditions under which
German cattle is kept may restrict infection, and (iii) only calves
are fully susceptible for BFV, most probably via nursing. In the
present study, we did not analyze the potential interplay
between BFV and other pathogens of cattle, a question that
can now be addressed using the novel BFV ELISAs.
We show that milk is a suitable surrogate for serum without
much forfeit of sensitivity. This feature and the fact that milk
can be sampled easily make milk highly suited for large-scale
screenings and livestock monitoring. In addition, we confirmed
previous reports that infected cows shed infectious BFV via
milk (Malmquist et al., 1969). It is currently open, whether the
infection is transmitted via free BFV particles or infected cells
as known for other milk-borne infections. Consistent with a
cell-associated transmission, BFV was recovered from the
cellular fractions of raw, untreated milk whereas the antibody-
containing whey did not allow BFV isolation. The relative ease
with which infectious BFV was recovered from raw milk and
blood, for instance without interferon suppression as suggested
for the isolation of SFVs (Falcone et al., 1999), is important
regarding BFV transmission since it indicates a substantial
infectivity present in milk or PBLs. Among cattle, nursing may
be the most important route of BFV spread as has been already
discussed by others (Lucas et al., 1986). Via raw milk and
related milk products but also other cattle-derived materials,
humans are also exposed to BFV. In developed countries, milk
is typically pasteurized before it gets to the consumer. However,
a growing number of people consumes untreated raw milk
products and is thus at an increased risk of interspecies
infections including BFV (Leedom, 2006).Table 2
PCR primers for generating BFV Gag, Bet, and Env GST fusion proteins
Primer Sequence
Gag-s 5′- CGAGTCGAATTCAATGGCTCTTAATG
Gag-as 5′- GCATGAGTCGACAGATGATTGCCCTT
Bet-s 5′- CGAGTCGAATTCGATGGCTAGCGGTG
Bet-as 5′- GCATGAGTCGACTTGAGATGTCTTCA
Env-s 5′- CGAGTCGAATTCACAATGGAAGGGA
Env-as 5′- GCATGAGTCGACTCCGTCCTGCGTTTThe BFVELISAs established here allow direct determination
of antibody pattern to potentially link individual pattern with
disease, the kinetics of infection, and the host–virus interplay.
Such sero-epidemiological studies for BFVwill certainly extend
our understanding of FV infection and replication in general and
the zoonotic potential of this milk-borne virus.
Materials and methods
Molecular cloning and recombinant proteins
The BFV gag gene was amplified by PCR with primers Gag-
s and Gag-as (Table 2) using cloned full-length infectious DNA
(Holzschu et al., 1998; Renshaw et al., 1991). The BFV bet
gene was amplified from a BFV particle cDNA preparation as
template with primers Bet-s and Bet-as. The ectodomain of the
Elp-SU part of BFV Env was amplified with primers Env-s and
Env-as. In all cases, the primers introduced an EcoRI site at the
5′ and a SalI site at the 3′ end of the amplicons. All PCRs were
done using Herculase Hotstart proof reading DNA polymerase
(Stratagene, Heidelberg, Germany) at 95 °C for 2 min plus 30
cycles of 95 °C for 30 s, 54 °C for 30 s, and 72 °C for 75 s. PCR
products were digested with restriction enzymes cleaving at the
introduced sites. Purified DNA fragments were fused in frame
between the 5′ GST domain and the 3′ SV40 tag (KPPTPPPE-
PET) of correspondingly digested pGEX4T3tag derivatives
(Sehr et al., 2002). Clones were identified by restriction enzyme
digestion and DNA sequencing.
For fusion protein expression, Escherichia coli BL21 cells
were transformed with pGEX-X-tag plasmids and recombinant
proteins were purified as described (Sehr et al., 2001, 2002).
GST capture ELISA
ELISAs were performed as described (Romen et al., 2006).
Briefly, 96-well microtiter plates (Thermo Labsystems,
Dreieich, Germany) were coated with glutathione casein,
blocked with blocking buffer (0.2% (w/v) casein in PBS,
0.05% (v/v) Tween 20) and then reacted with 100 μl cleared E.
coli lysates containing the GST-tag or GST-X-tag fusion proteins
(0.25 μg/μl total protein lysate in blocking buffer).
Sera from naturally BFV-infected and uninfected cattle were
preincubated at a dilution of 1:50 in blocking buffer containing
2 μg/μl total protein from GST-tag expressing E. coli BL21
(Romen et al., 2006), milk was preincubated at a dilution of 1:5.
Serum and milk samples were incubated for 1 h at RT in the
coated ELISA plate wells, washed, and incubated for 1 h at RTRestriction site
ACTTCGACCCTATAGC-3′ EcoRI
GATTTCCACTTGAAGTGG-3′ SalI
GAACGCCGGAGAAAGC-3′ EcoRI
GATCCAGGTCTTCTTCAC-3′ SalI
GCTATTGAGAGC-3′ EcoRI
TATTCTGATAAC-3′ SalI
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1:5000 dilution). Substrate reaction and quantification were
done as described (Sehr et al., 2001). Unless otherwise stated,
all incubations were performed in 100 μl/well.
For each serum, the background absorbance with GST-tag
was determined and subtracted from the absorbance with the
GST-X-tag protein to calculate its specific reactivity against the
BFV antigens. Measurements were done in duplicate on
different plates and the mean value of the specific reactivity
of the duplicate was taken as the readout. Sero-reactivity is
expressed as optical density (or milli optical density) at wave
length 450 nm; OD450 and mOD450, respectively. Standard cut-
off values were calculated from all negative reference sera as the
mean value (M) plus three standard deviations (SD): M+3 SD.
Stringent cut-off values are the twofold standard cut-off:
2×(M+3 SD).
For BFV cell ELISA (Materniak, manuscript in preparation),
Cf2Th cells were seeded in ELISA plates, BFV- and mock-
infected, and fixed with 40% acetone. Cattle sera were
incubated for 1 h at 37 °C at a dilution of 1:100, washed, and
reacted with anti-bovine IgG–horseradish peroxidase conju-
gate. After substrate reaction, reactivity was assayed at 405 nm.
AGID assays were performed according to Johnson et al.
(1983).
Animals
Serum samples used as reference material were obtained
from 3 to 6 years old Holstein-Friesian cows from two herds
from North Poland. Polish field sera were from 4 to 8 years old
Holstein-Friesian cows from 3 different herds from North
Poland. Sera from Red Holstein-Friesian cattle grown up in the
Northeast of Germany were randomly selected from three
commercial farms. All animals were about 5 to 7 months of age.
Cows from Southern Germany were Holstein-Friesian and
other, local breeds aged between 2.5 and 6 years. All animals
analyzed were clinically healthy.
Virus isolation from PBLs, milk cells and saliva
Fresh EDTA blood was centrifuged, the plasma was
collected for ELISA testing and the buffy coat cells were
removed (Alke et al., 2000) and incubated with ACT
erythrocyte lysis buffer (140 mM NH4Cl, 16.5 mM Tris/HCl;
Michel et al., 2002). After erythrocyte lysis, the PBLs were
incubated with BFV-permissive dog thymocytes (Cf 2Th cells)
and passaged for at least 3 weeks.
Milk samples were centrifuged, the liquid phase was
collected for ELISA testing and pelleted milk cells resuspended
in PBS were used for co-cultivation as described above.
Saliva was harvested with cotton plugs from the mouth of
cattle. The plugs were incubated in cell culture medium
containing the antibiotics penicillin, streptomycin, gentamycin,
amphotericin and the fungicide nystatin (Alke et al., 2000).
After low-speed centrifugation without any prior filtration, the
supernatants were applied to Cf2Th cells and cultured with
daily medium changes as described (Alke et al., 2000). During 3to 4 weeks of passages, Cf2Th cells were examined for
cytopathic effects by phase contrast microscopy and addition-
ally by direct IF.
Direct immunofluorescence
Cf2Th cells from co-cultivation experiments were seeded on
glass coverslips. After 2 days, the coverslips were washed with
PBS and cells were fixed at least 20 min in ice cold 100%
methanol/0.02% EGTA. Cells were rehydrated for 20 min in
PBS and unspecific protein-binding sites were blocked with 3%
BSA in PBS for 30 min. A FITC-conjugated, bovine polyclonal
BFV reference antibody (diluted 1:500 in PBS with 0.3% BSA)
was incubated for 60 min followed by three 5-min PBS wash
steps (Granzow et al., 1983). Coverslips were washed in
double-distilled water and ethanol and then mounted.
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